Table 1.
Demographic, clinical and neuropathologic data of control, DLB and Alzheimer’s disease cases
| Case | Diagnosis | Gender | Age at death | PMI, h | McKeith type | LB Braak stage | Braak NFT stage |
|---|---|---|---|---|---|---|---|
| 1 | Control | M | 82 | 24 | - | 0 | 0 |
| 2 | Control | M | 63 | 16 | - | 0 | 0 |
| 3 | Control | F | 77 | 75 | - | 0 | I |
| 4 | Control | M | 78 | 39 | - | 0 | I |
| 5 | Control | F | 83 | 8 | - | 0 | II |
| 6 | DLB | M | 71 | 8 | Neocortical | 5 | III |
| 7 | DLB | M | 83 | 24 | Neocortical | 5 | IV |
| 8 | DLB | F | 62 | 9 | Neocortical | 5 | IV |
| 9 | DLB | M | 77 | 36 | Neocortical | 5 | III |
| 10 | DLB | F | 83 | 24 | Neocortical | 6 | VI |
| 11 | AD | M | 81 | 74 | - | 0 | V |
| 12 | AD | M | 72 | 109 | - | 0 | VI |
| 13 | AD | M | 81 | 83 | - | 0 | VI |
| 14 | AD | M | 85 | 91 | - | 0 | VI |
| 15 | AD | F | 90 | 18 | - | 0 | V |
AD = Alzheimer’s disease; LB = Lewy body; NFT = neurofibrillary tangle; PMI = post-mortem interval.